Maternal methadone dose, placental methadone concentrations, and neonatal outcomes. - Wikidata - wikimedia - TriplyDB

Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.

Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.

http://www.wikidata.org/entity/Q34626408

about

Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women The opioid system and brain development: effects of methadone on the oligodendrocyte lineage and the early stages of myelination.Fetal assessment before and after dosing with buprenorphine or methadone Beneficial effects of co-treatment with dextromethorphan on prenatally methadone-exposed offspring Methadone and metabolites in hair of methadone-assisted pregnant women and their infants.A Multidisciplinary Approach to the Treatment of Co-occurring Opioid Use Disorder and Posttraumatic Stress Disorder in Pregnancy: A Case Report.Obstetric Pharmacokinetic Dosing Studies are Urgently Needed.Bioanalysis during pregnancy: recent advances and novel sampling strategies.Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy.Simultaneous determination of opiates, methadone, amphetamines, cocaine, and metabolites in human placenta and umbilical cord by LC-MS/MS.Oral morphine weaning for neonatal abstinence syndrome at home compared with in-hospital: an observational cohort study.Meconium drug testing reveals maternal misuse of medicinal opioids among addicted mothers.Will Widespread Synthetic Opioid Consumption Induce Epigenetic Consequences in Future Generations?Screening Pregnant Women and Their Neonates for Illicit Drug Use: Consideration of the Integrated Technical, Medical, Ethical, Legal, and Social Issues

P2860

Q33760424-0E34763E-5F19-4977-849D-2A7079B2CBBC Q34000757-99FD659D-185B-4D3A-AE42-6BA50CC9FF67 Q34244903-5B329D67-FE12-47E4-BB9D-C6815CECA638 Q34775584-68EB1798-2FF7-47E7-A0DC-C4E31D75BF94 Q35224152-60586778-90E0-42B4-B67C-88F3DABA1DA1 Q36036257-C62AB2BA-5316-48D7-94BC-A3D903BE6EF7 Q36603506-C7DE855E-DA8C-4ABD-8B70-BA62A2DAB963 Q37575742-5A36B54F-3790-4CC5-B525-0EEF352A9CBC Q38296225-D87BC4B8-5372-46C5-BAA8-A532C0B4F07D Q39422252-E34DD315-BF04-4DEF-BD73-9075038B598A Q48091451-6F7131B2-0F5F-4823-9514-6062578FB669 Q51040247-C9E568DA-BE35-4DCC-A28F-8A6C37536821 Q52302206-5C7C4D86-FD0F-4F41-8EE2-5E769FAA5C7E Q57177304-488294EE-5A3A-4BA1-96B7-128C58E81938 Q58657183-C8E11A91-FA35-4200-A80B-4502FBA5327C

P2860

Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.

http://www.wikidata.org/entity/Q34626408

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.

@ast

Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.

@en

Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.

@nl

type

label

Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.

@ast

Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.

@en

Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.

@nl

prefLabel

Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.

@ast

Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.

@en

Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.

@nl

P1433

Q34626408-9EBC21E4-0F49-4A10-826F-13B981BA8C61

P1476

Q34626408-5CE7A6F2-4566-45BB-B839-EFCE5550C61E

P2093

Q34626408-02DDF682-79CE-472F-97CA-4908E101DC71

Q34626408-13AB5AD5-A78D-4DF9-96E8-EA55B327E5E9

Q34626408-A8A1BAD2-0CB9-4460-A247-6719E2E5ED4F

Q34626408-AC8B4106-09DD-4ED5-B591-8C0EBBCB55A9

Q34626408-BA0FECD2-DC7E-4243-B7FA-3B79690F2210

P2860

Q34626408-0E3B0A10-02AF-465B-8463-28083B280040

Q34626408-24A26A2D-3569-4F42-ABBC-51FBEDBD0C4F

Q34626408-2BB98223-2E4A-476D-943F-69309F361FF3

Q34626408-36945F80-2B62-4D0E-803B-B478CE388C9A

Q34626408-3F88DD51-06E8-4BFC-95D7-14263444B028

Q34626408-42BD2D50-2F80-4F4D-9F43-82E0CDE06E6C

Q34626408-43441975-8795-447F-96BA-A20174E5752B

Q34626408-44E1C9CC-948F-4EB4-BAD7-0D7A8EFCA375

Q34626408-4851816F-2D36-4A81-8596-004D34AF8179

Q34626408-54EB59DA-621B-4C81-8FB4-CE0AE089103B

P304

Q34626408-9231FDF9-0E85-498C-ABBF-3F9FD8AE7D32

P31

Q34626408-A154A22F-C97A-4DD0-B375-8A0C9E140092

P356

Q34626408-D65AC3D1-9953-40CA-8AC1-E84CA61A76E3

P407

Q34626408-88D92880-F624-49DD-ACEB-574E1C9F376A

P433

Q34626408-FF918743-F9F8-4231-9257-405E45448782

P478

Q34626408-1D01FC56-DD9C-4B38-9DD8-54138C89484B

P50

Q34626408-9C7A772A-6065-4A6F-863C-A78B41DEADAA

P577

Q34626408-7AEFA0F2-F84D-4DAF-BB4A-DF2AE7A6FD95

P5875

Q34626408-E1BD0214-104A-4C5D-B316-EAFFC6E7C881

P698

Q34626408-0ED10D7A-FCE2-4F63-8671-3F7934EF5D66

P932

Q34626408-8142AA31-F565-43B5-9C45-26E821B8B415

P356

CLINCHEM.2010.154864

P1433

Clinical Chemistry

P1476

Maternal methadone dose, placental methadone concentrations, and neonatal outcomes

@en

P2093

Diaa M Shakleya

http://www.w3.org/2001/XMLSchema#string

Hendreé E Jones

http://www.w3.org/2001/XMLSchema#string

Marilyn A Huestis

http://www.w3.org/2001/XMLSchema#string

Rolley E Johnson

http://www.w3.org/2001/XMLSchema#string

Teresa R Gray

http://www.w3.org/2001/XMLSchema#string

P2860

Methadone levels and neonatal withdrawal

Determination of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, 2-ethyl-5-methyl-3,3-diphenylpyraline and methadol in meconium by liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry.

Fetal hepatic drug elimination.

Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone.

Confirmation of gestational exposure to alprazolam by analysis of biological matrices in a newborn with neonatal sepsis.

Drug abuse's smallest victims: in utero drug exposure.

Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry.

A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium

Simultaneous quantification of methadone, cocaine, opiates, and metabolites in human placenta by liquid chromatography-mass spectrometry

Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome?

P304

449-458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1373/CLINCHEM.2010.154864

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49765349

http://www.w3.org/2001/XMLSchema#string

P698

21245372

http://www.w3.org/2001/XMLSchema#string

P932

4543294

http://www.w3.org/2001/XMLSchema#string